Novel mutation in the tyrosine kinase domain of FGFR2 in a patient with Pfeiffer syndrome.


Autoria(s): Zankl A.; Jaeger G.; Bonafé L.; Boltshauser E.; Superti-Furga A.
Data(s)

2004

Resumo

Mutations in the fibroblast growth factor receptor 2 (FGFR2) cause a variety of craniosynostosis syndromes. The mutational spectrum tends to be narrow with the majority of mutations occurring in either exon IIIa or IIIc or in the intronic sequence preceding exon IIIc. Mutations outside of this hotspot are uncommon and the few identified mutations have demonstrated wide clinical variability, making it difficult to establish a clear-cut genotype-phenotype correlation. To better delineate the clinical picture associated with these unusual mutations, we describe a severely affected patient with Pfeiffer syndrome and a missense mutation in the tyrosine kinase (TK) domain of FGFR2.

Identificador

http://serval.unil.ch/?id=serval:BIB_6BDD7112100A

isbn:1552-4825

pmid:15523615

doi:10.1002/ajmg.a.30366

isiid:000225530200010

Idioma(s)

en

Fonte

American journal of medical genetics. Part A, vol. 131, no. 3, pp. 299-300

Palavras-Chave #Acrocephalosyndactylia; Base Sequence; DNA Primers; Genotype; Humans; Infant, Newborn; Mutation; Phenotype; Receptor Protein-Tyrosine Kinases; Receptor, Fibroblast Growth Factor, Type 2; Receptors, Fibroblast Growth Factor
Tipo

info:eu-repo/semantics/article

article